Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Hospital A.C. Camargo

Status: Completed

Conditions: Hearing Loss

Study type: Observational

Funder types: Other

Identifiers

NCT01102621

HL1

Details and patient eligibility

About

Hypothesis: Treatment for head and neck tumors often involve methods that affect the auditory system and cause hearing loss. Neck dissection negatively impacts the lymphatic drainage, chemotherapy uses ototoxic drugs, radiotherapy affects blood flow and tissue radiation is toxic to the ear and may lead to hearing losses of various types and degrees.

Objective: To investigate occurrences of hearing loss and complaints among patients with head and neck tumors who underwent radiotherapy.

Study design: Prospective, case-control study. Setting: Tertiary care center hospital.

Subjects and Methods: 282 subjects were evaluated, 141 with head and neck tumors and 141 as an age-matched control group. The controls had never undergone oncological treatment that put their hearing at risk. All subjects underwent audiological evaluation, including the HHIE questionnaire, pure tone audiometry, speech audiometry and immittance audiometry. The radiation dose received by the auditory system was calculated based on the percentage of the external auditory canal included in the radiation field.

Enrollment: 282 patients

Sex: All

Ages: 11 to 84 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The group of exposed individuals
• had to be patients with disease-free survival interval of at least two years subsequent to treatment for head and neck cancer
• radiotherapy alone or in combination, in which the auditory system was included in the field of irradiation.
• The group of non-exposed individuals (control group)
• had to be patients who had not undergone oncological treatment that put their hearing at risk
• age-matched (2 years). This group was formed by individuals who had had pelvic tumors or skin tumors and who had only undergone local surgery to remove their tumors, and by female volunteers from the hospital.
• All of these individuals were asked whether they would be willing to participate in a study, without knowing in advance whether they had any previous hearing problems or complaints.

Exclusion criteria

• congenital hearing loss
• otological surgery

Trial design

282 participants in 2 patient groups

case-control, head and neck cancer with radiotherapy

Description:

The group of exposed individuals had to be patients with disease-free survival interval of at least two years subsequent to treatment for head and neck cancer by means of radiotherapy alone or in combination, in which the auditory system was included in the field of irradiation.

case-control, head an neck cancer without radiotherapy

Description:

The group of non-exposed individuals (control group) had to be patients who had not undergone oncological treatment that put their hearing at risk and who were age-matched (2 years). This group was formed by individuals who had had pelvic tumors or skin tumors and who had only undergone local surgery to remove their tumors, and by female volunteers from the hospital. All of these individuals were asked whether they would be willing to participate in a study, without knowing in advance whether they had any previous hearing problems or complaints.